diclazuril 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5524 | 101831-37-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000981 | Antiprotozoal Agents |
| MeSH PA | D003049 | Coccidiostats |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Chickens | Coccidiosis caused by Eimeria tenella | Indication |
| Chickens | Coccidiosis caused by Eimeria necatrix | Indication |
| Chickens | Coccidiosis caused by E acervulina | Indication |
| Chickens | Coccidiosis caused by E brunetti | Indication |
| Chickens | Coccidiosis caused by E mivati | Indication |
| Chickens | Coccidiosis caused by E maxima | Indication |
| Chickens | To reduce lesion scores and to improve performance and health of birds challenged with E maxima | Indication |
| Horses | Equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona | Indication |
| Turkeys | Coccidiosis caused by Eimeria adenoeides | Indication |
| Turkeys | Coccidiosis caused by E gallopavonis | Indication |
| Turkeys | Coccidiosis caused by Eimeria meleagrimitis | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Clinacox | Elanco US Inc. | 1 |
| Clinacox and BMD | Elanco US Inc. | 2 |
| Clinacox and Flavomycin | Elanco US Inc. | 2 |
| Clinacox and BMD | Elanco US Inc. | 2 |
| Clinacox and Flavomycin | Elanco US Inc. | 2 |
| Protazil | Intervet Inc. | 1 |
| Clinacox and Stafac | Elanco US Inc. | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEMBL284733 | ChEMBL_ID |
| C057884 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11398 | DRUGBANK_ID |
| 019307 | NDDF |
| C0057874 | UMLSCUI |
| 5971 | INN_ID |
| D03794 | KEGG_DRUG |
| 456389 | PUBCHEM_CID |
| 1368201 | RXNORM |
| K110K1B1VE | UNII |
Pharmaceutical products:
None